Clinical Gastroenterology and Hepatology: Volume 20 (Issue 1 to Issue 12)
Clinical Gastroenterology and Hepatology (CGH) is a peer-reviewed journal with a well-defined mission and scope in the field of clinical gastroenterology and hepatology. Here are the key features of CGH:
Mission and Scope:
- CGH aims to cover a broad spectrum of topics in clinical gastroenterology and hepatology, including advancements in diagnosis, endoscopy, intervention, and therapeutics in various conditions, such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion.
Content Diversity:
- The journal publishes a range of content, including original research articles and scholarly reviews, all with the goal of immediate relevance to the practice of gastroenterology and hepatology.
- Additionally, CGH features invited key reviews and articles on endoscopy and practice-based technology, health-care policy, and practice management.
- Multimedia elements, such as images, video abstracts, and podcasts, enhance the journal’s offerings.
Impact and Recognition:
- CGH is highly regarded in the field and is ranked 7th out of 93 journals in the gastroenterology and hepatology category, according to the 2021 Journal Citation Reports© by Clarivate Analytics. It boasts an impressive Impact Factor of 13.576.
Efficient Review Process:
- Authors submitting their work to CGH can expect rapid decision-making, with most manuscripts evaluated in under three weeks.
Broad Readership:
- The journal reaches a wide audience, with distribution to 20,300 individuals and institutions worldwide.
- CGH also engages with readers through updates and commentary on social media platforms like Facebook and Twitter.
Clinical Gastroenterology and Hepatology stands as a reputable source of information and research findings in the field of clinical gastroenterology and hepatology. Its diverse content, rapid review process, and active engagement with readers make it a valuable resource for clinicians and researchers alike.
Volume 20, Issue 1: Pages A1-A22, e1-e10, 1-250 (January 2022)
Volume 20, Issue 2: Pages A1-A32, e11-e346, 251-474 (February 2022)
Volume 20, Issue 3: Pages A1-A20, e347-e644, 475-718 (March 2022)
Volume 20, Issue 4: Pages A1-A26, e645-e914, 719-968 (April 2022)
Volume 20, Issue 5: Pages A1-A34, e915-e1222, 969-1194 (May 2022)
Volume 20, Issue 6: Pages A1-A22, e1223-e1516, 1195-1424 (June 2022)
Volume 20, Issue 7: Pages A1-A26, e1517-e1526, 1425-1622 (July 2022)
Missing the Mark: Hepatic Encephalopathy
This supplement on Missing the Mark: Hepatic Encephalopathy is supported by an independent educational grant from Salix Pharmaceuticals, a division of Bausch Health US, LLC. Salix Pharmaceuticals had no involvement in the creation of the content, including author selection, manuscript development or peer review. The views and opinions expressed in the articles are those of the authors.
Volume 20, Issue 8, Supplement, Pages A1-A2, S1-S30 (August 2022)
Reviews
There are no reviews yet.